新闻
BLRX
--
0.00%
--
微牛提供丰富的实时BLRX股票新闻,让你可以通过多个平台了解BLRX股票行情最新动态,这些免费的BioLine RX新闻可以帮助你做出明智投资。
BLRX 简况
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
展开